Full-Time

Director of Pharmacy Operations

Non-Dispensing Pharmacy

Updated on 9/4/2026

Inizio Engage

Inizio Engage

501-1,000 employees

Provides integrated data insights for pharma

Compensation Overview

$105k - $195k/yr

Louisville, KY, USA

In Person

Candidates must reside within the Louisville metropolitan area and work onsite Monday through Friday.

Bachelor's, PharmD

Category
Medical, Clinical & Veterinary (1)
Required Skills
Quality Assurance (QA)
HIPAA

Get referred to Inizio Engage

See people who can refer or advise you

Requirements
  • A B.S. Pharm or PharmD from an accredited school of pharmacy is required.
  • A minimum of 5+ years of pharmacy experience, including leadership and regulatory oversight responsibilities, is required.
  • An active, unrestricted pharmacist license in Kentucky is required.
  • The candidate must be able to obtain additional state licensure as directed by the business.
  • Strong knowledge of non-dispensing pharmacy requirements and compliance frameworks is required.
  • Demonstrated experience interacting with clients and participating in audits or business reviews is required.
  • Proven leadership and team management skills are required.
  • Excellent written and verbal communication skills are required.
  • The candidate must be able to work onsite in the Louisville, Kentucky metropolitan area.
Responsibilities
  • Oversee non-dispensing pharmacy-related HUB services, ensuring adherence to established business rules, clinical standards, and client program requirements.
  • Serve as the designated Pharmacist in Charge for the non-dispensing pharmacy, ensuring compliance with all applicable state and federal regulations for the digital front door pharmacy.
  • Partner with HUB leadership to ensure program performance meets or exceeds established Service Level Agreements and quality metrics.
  • Coordinate with patient HUB teams to ensure accurate prescription intake, benefits verification alignment, clinical review workflows, and compliant case documentation.
  • Maintain accountability for pharmacy licensure, regulatory inspections, audits, policies, procedures, and recordkeeping requirements.
  • Serve as a pharmacy subject matter expert in client meetings, audits, business reviews, and implementation discussions.
  • Provide consultative support to prescribers, patients, caregivers, and internal teams within a non-dispensing model.
  • Oversee pharmacy staff and technician activities, ensuring appropriate supervision, workflow integrity, and regulatory adherence.
  • Ensure appropriate documentation, reporting, quality assurance, and security protocols are consistently followed.
  • Lead continuous quality improvement initiatives and maintain readiness for board of pharmacy inspections and client audits.
  • Maintain confidentiality of patient and program information in accordance with HIPAA and other regulatory standards.
  • Support business growth initiatives, including licensing in additional states as required.
Desired Qualifications
  • Prior experience as Pharmacist in Charge or a comparable pharmacy leadership role is strongly preferred.
  • Additional state pharmacist licenses are preferred.
  • Experience supporting specialty pharmacy, HUB services, or non-commercial dispensing pharmaceutical programs is preferred.

Inizio Engage turns scattered data into integrated insights and learning solutions for the pharmaceutical and biotechnology sectors. Its PROPENSITY4 data platform combines data from multiple sources to support decision making across customer needs, commercial operations, and strategic goals. The ecosystem includes Ashfield Excellence Academy, Axiom, Cormis, and Logicearth, which provide training, communications, and capability-building programs for pharma commercial and medical teams. By pairing data analytics with targeted training and talent development, the company helps patients, healthcare professionals, and pharmaceutical firms improve outcomes and gain competitive advantages.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Upper Dublin Township, Pennsylvania

Founded

N/A

Get referred to Inizio Engage

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 2026 Connected Insights expands APAC medical information and adds speech analytics, virtual agents.
  • April 2026 Hub Services launch strengthens patient access programs at Asembia, a major industry venue.
  • September 2026 events calendar shows active marketing at PIPA, Fierce Pharma Week, and expopharm.

What critics are saying

  • Inizio's AI tools commoditize skilled service labor, pressuring pricing when pharma buyers benchmark automation in 2027.
  • Revelio estimated 332 active job postings in 2026, down 102.4 percent from 2025.
  • If major clients internalize patient support, Engage loses scale fast.

What makes Inizio Engage unique

  • Inizio Engage runs 6,000 experts across 20+ countries, giving local execution at global scale.
  • Its April 2026 Hub Services unify access, reimbursement, pharmacy, and adherence in one platform.
  • Connected Insights turns one million scientific interactions into medical-information intelligence and AI-enabled workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Private Medical Insurance

Life Insurance

Pension Scheme

Hybrid Work Options

Paid Vacation

401(k) Retirement Plan

Company News

PMGroup
Dec 11th, 2025
Inizio Engage CEO Jim Sage featured in pharmaphorum's "12 Questions" series

Inizio Engage CEO Jim Sage featured in pharmaphorum's "12 Questions" series. Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. We're pleased to share that Jim Sage, Global CEO and President of Inizio Engage, has been featured in pharmaphorum's latest "12 Questions" interview series. In the conversation, Jim reflects on his career across international markets, his motivations as a leader, and the experiences that have shaped his approach to building high-performing teams. He also explores some of the most pressing challenges facing the pharmaceutical industry today, including pricing pressures, launch performance, and the need for new reimbursement models. Jim highlights how data, technology, and AI are already transforming the way organisations operate, and discusses the growing importance of patient-centric approaches, from HUB services to personalised support throughout the treatment journey. This content was provided by Inizio Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek(R) 2025 in Atlanta, experts from across Inizio reflected... Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making. Inizio today announced the launch of InConcert(TM), a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle. Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders. As the global hematology community prepares for the 67th ASH(R) Annual Meeting and Exposition, Inizio experts share their perspectives on what's driving the field forward - and how pharma companies... At Inizio Medical, we believe AI isn't replacing Medical Affairs - it's redefining what's possible. Our platform, iON.AI(TM), enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless... Discover how Inizio experts are shaping the future of obesity care - where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact. At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact - discover how this human-centered innovation is defining the... Inizio is leading the way in Intelligent Commercialization(TM) by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization. * 1 * 2 * 3 * 4 * 5 * 6 * 7 * 8 * 9 * 10 * 11 * 12 * 13 * 14 * 15 * 16 * 17 * 18 * 19 * 20 * 21 * 22 * 23 * 24 * 25 * 26 * 27 * 28 * 29 * 30 * 31 * 32 * 33 * 34 * 35 * 36 * 37 * 38 * 39 * 40 * 41 * 42 * 43 * 44 * 45 * 46 * 47 * 48 * 49 * 50

PMGroup
Sep 24th, 2025
Inizio celebrates six finalist honors at the 2025 PM360 Trailblazer Awards

We're proud to announce that our teams across Inizio Evoke, Inizio Engage, and Inizio Medical have been named finalists in six prestigious categories at the 2025 PM360 Trailblazer Awards, which recognize excellence and innovation in healthcare marketing.

Bdaily
Sep 14th, 2025
Inizio names new chief executive

Inizio, a global commercialisation partner to health and life sciences companies, has appointed Ryan Quigley as chief executive.

Inizio Engage
Mar 5th, 2025
Inizio Engage choose Egg as Patient Support Program implementation partner in Italy.

After a review of potential Patient Support Program (PSP) partners in Italy, Inizio Engage has formed a collaboration with Egg, head quartered in Milan.

MM+M
Feb 12th, 2025
The Escalator: Pfizer, Vertex Pharmaceuticals, Inizio and more

Inizio announced that Remco op den Kelder has been appointed to the president of Inizio Advisory and Jim Sage will become president of Inizio Engage.